FDA Inspection
Dr. Adam J. SingerDr. Adam J. Singer – FDA Inspection, Mar 6, 2017
Record Details
This FDA Inspection record concerns Dr. Adam J. Singer, with an inspection on March 6, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2c7a72b0-1929-4f72-8fcd-3ff4e40a541a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1005225
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dr. Adam J. Singer
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 4, 2009 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Dr. Adam J. Singer
- FDA Inspection 1130877 - 2020-09-29
- FDA Inspection 561042 - 2009-02-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.